Lind Kevin Robert 4
4 · Longboard Pharmaceuticals, Inc. · Filed Feb 9, 2024
Insider Transaction Report
Form 4
Lind Kevin Robert
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-02-08+332,134→ 332,134 totalExercise: $19.32Exp: 2034-02-07→ Voting common stock (332,134 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 8, 2024.